Treatment by the pulmonary route can be used for administration of drugs that act locally in the lungs (e.g. treatment of lung cancer, chronic obstructive pulmonary disease, asthma) or non-invasive administration of drugs that act systemically. The potential of drug delivery systems formed from non-ionic surfactants or natural products i.e. proteins and polysaccharides for pulmonary delivery are discussed.
|Number of pages||28|
|Journal||Current Pharmaceutical Design|
|Publication status||Accepted/In press - 6 Dec 2015|
- drug delivery systems
- non-ionic surfactant vesicles